Standard Family Office LLC Bristol Myers Squibb CO Transaction History

Standard Family Office LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$0.13 - $76.84 $15 - $9,220	120 New	120 $9,000
Q3 2021 Nov 15, 2021	SELL	$59.17 - $69.31 $5,857 - $6,861	-99 Closed	0 $0
Q2 2021 Aug 13, 2021	SELL	$61.91 - $67.42 $100,665 - $109,624	-1,626 Reduced 94.26%	99 $7,000
Q4 2020 Feb 16, 2021	BUY	$57.74 - $65.43 $99,601 - $112,866	1,725 New	1,725 $107,000

2,428

1.5B

29.7M

32.2M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $113B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Standard Family Office LLC, based on Form 13F filings with the SEC.

Stay updated on Standard Family Office LLC with notifications on news.